US EditionPublished • loading... • Updated
Transthyretin Cardiac Amyloidosis (ATTR-CM) Treatment
Summary by EverydayHealth.com
1 Articles
1 Articles
Transthyretin Cardiac Amyloidosis (ATTR-CM) Treatment
Treatment options for transthyretin cardiac amyloidosis (ATTR-CM), also known as transthyretin amyloid cardiomyopathy, have grown considerably in recent years. This condition is caused by an irregular protein, called transthyretin (TTR), that’s produced in the liver and builds up in the heart. This buildup causes the heart walls to stiffen, making it harder for the heart to pump blood, eventually leading to heart failure and frequently to early …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
